WO2024200489 - BLOOD BIOMARKERS FOR MONITORING CHANGES IN THE AMOUNT OF VISCERAL ADIPOSE TISSUE

National phase entry:
Publication Number WO/2024/200489
Publication Date 03.10.2024
International Application No. PCT/EP2024/058201
International Filing Date 27.03.2024
Title **
[English] BLOOD BIOMARKERS FOR MONITORING CHANGES IN THE AMOUNT OF VISCERAL ADIPOSE TISSUE
[French] BIOMARQUEURS SANGUINS POUR SURVEILLER DES CHANGEMENTS DE LA QUANTITÉ DE TISSU ADIPEUX VISCÉRAL
Applicants **
RANDOX LABORATORIES LTD
Inventors
INNOCENZI, Paul
FITZGERALD, Peter
MCCONNELL, Ivan
Priority Data
2304612.1   29.03.2023   GB
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting1965
EPO Filing, Examination, Granting8133
Japan Filing, Examination, Granting2116
South Korea Filing, Examination, Granting1921
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 18,875

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] Methods are described for the biomarker-based identification of a change in the amount of visceral adipose tissue (VAT) in individuals with a healthy BMI and a healthy waist circumference. The early identification of VAT changes using commonly measured clinical biomarkers when incorporated with exercise and nutritional advice enables the expeditious implementation of the END approach (Exercise Nutrition & Diagnostics) to manage the burgeoning overweight and obesity pandemic.[French] L'invention concerne des procédés pour l'identification basée sur un biomarqueur d'un changement de la quantité de tissu adipeux viscéral (VAT) chez des individus présentant un IMC sain et une circonférence de taille saine. L'identification précoce de changements de VAT à l'aide de biomarqueurs cliniques couramment mesurés lorsqu'elle est incorporée à des conseils d'exercice et de nutrition permet la mise en œuvre accélérée de l'approche END (exercice, nutrition et diagnostic) pour gérer la pandémie de surpoids et d'obésité en plein essor.

Rejoining the server...